Search Results 1051-1060 of 15856 for syphilis
The study will evaluate the efficacy and safety of gevokizumab in treating active ulcers of pyoderma gangrenosum (PG). Participation eligibility. Participant ...
The purpose of this study is to evaluate the outcome of hospitalization related to the presence of cirrhosis. We are participating in optional blood, saliva, ...
Rochester, Minn. The purpose of this research study is to improve our understanding of normal liver and gallbladder function and liver and gallbladder diseases ...
Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures. · Patent Foramen Ovale ( ...
This oral contraceptive, sometimes called the minipill, contains only the hormone progestin and no estrogen.
A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in ...
The Vaccine Research Group at Mayo Clinic, led by Dr. Poland, Dr. Kennedy and Dr. Ovsyannikova researches vaccines, immunity and the threat of infectious ...
AbiMansour J, Wu TT, Sweetser S. A Distinct and Potentially Deadly Cause of Gastric Polyposis. Gastroenterology. 2022 Aug; 163(2):379-381. Epub 2022 Apr 27.
Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Participation eligibility.
The purpose of this study is to determine the proportion of patients achieving both complete remission and seronegativity for Anti-Neutrophil Cytoplasmic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.